Literature DB >> 12637762

Cyclooxygenase-2 expression in canine mammary tumors.

M Doré1, I Lanthier, J Sirois.   

Abstract

Mammary tumors are the most common neoplasms in female dogs. Induction of cyclooxygenase-2 (COX-2) has been implicated in various cancers in humans. However, expression of COX-2 has not been investigated in canine mammary tumors. Normal mammary gland (n = 4), simple or complex adenomas (n = 63), and simple or complex adenocarcinomas (n = 84) were studied by immunohistochemistry. Results showed that COX-2 was not expressed in the normal gland but was detected in 24% of adenomas and in 56% of adenocarcinomas (P < 0.001). The incidence of COX-2 expression and the intensity of the COX-2 signal were higher in adenocarcinomas than in adenomas (P < 0.001). These results demonstrate for the first time that COX-2 is induced in a proportion of canine mammary tumors and that COX-2 expression is more frequent and more intense in malignant than in benign tumors, suggesting a potential role for COX-2 in canine mammary tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637762     DOI: 10.1354/vp.40-2-207

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  9 in total

1.  MicroRNA expression in canine mammary cancer.

Authors:  R Michelle Boggs; Zachary M Wright; Mark J Stickney; Weston W Porter; Keith E Murphy
Journal:  Mamm Genome       Date:  2008-07-30       Impact factor: 2.957

2.  Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment.

Authors:  Carlos H de M Souza; Evandro Toledo-Piza; Renee Amorin; Andrigo Barboza; Karen M Tobias
Journal:  Can Vet J       Date:  2009-05       Impact factor: 1.008

Review 3.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

Review 4.  The role of COX expression in the prognostication of overall survival of canine and feline cancer: A systematic review.

Authors:  Hugo Gregório; Tomás R Magalhães; Isabel Pires; Justina Prada; Maria I Carvalho; Felisbina L Queiroga
Journal:  Vet Med Sci       Date:  2021-03-10

5.  The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study.

Authors:  Jian Huang; Di Zhang; Fuqiang Xie; Degui Lin
Journal:  J Vet Sci       Date:  2015-06-17       Impact factor: 1.672

6.  Meloxicam decreases the migration and invasion of CF41.Mg canine mammary carcinoma cells.

Authors:  María P Iturriaga; Rodolfo Paredes; Jose I Arias; Cristian G Torres
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

Review 7.  Current biomarkers of canine mammary tumors.

Authors:  Ilona Kaszak; Anna Ruszczak; Szymon Kanafa; Kamil Kacprzak; Magdalena Król; Piotr Jurka
Journal:  Acta Vet Scand       Date:  2018-10-29       Impact factor: 1.695

8.  Ultrasonographic assessment of renal perfusion in bitches with mammary carcinoma treated with long-term carprofen.

Authors:  Cristhian Rene Vargas Estrada; Bruna Fernanda Firmo; Daniele Belchior Vela; Marjury Cristina Maronezi; Ricardo Andrés Ramirez Uscategui; Beatriz Gasser; Marcus Antônio Rossi Feliciano; Letícia Pavan; Luiz Paulo Nogueira Aires; Gabriela Piovan Lima; Andrigo Barboza De Nardi
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

Review 9.  In vitro comparative models for canine and human breast cancers.

Authors:  Simona Visan; Ovidiu Balacescu; Ioana Berindan-Neagoe; Cornel Catoi
Journal:  Clujul Med       Date:  2016-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.